$SMTK
SmartKem, Inc.

2021 Form 10-K Financial Statement

#000155837022004423 Filed on March 28, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $18.00K $94.00K
YoY Change -80.85%
Cost Of Revenue $8.000K $55.00K
YoY Change -85.45%
Gross Profit $10.00K $39.00K
YoY Change -74.36%
Gross Profit Margin 55.56% 41.49%
Selling, General & Admin $8.069M $1.707M
YoY Change 372.7%
% of Gross Profit 80690.0% 4376.92%
Research & Development $8.199M $4.319M
YoY Change 89.84%
% of Gross Profit 81990.0% 11074.36%
Depreciation & Amortization $209.0K $197.0K
YoY Change 6.09%
% of Gross Profit 2090.0% 505.13%
Operating Expenses $17.60M $6.026M
YoY Change 192.02%
Operating Profit -$16.30M -$4.550M
YoY Change 258.29%
Interest Expense $19.00K $6.835M
YoY Change -99.72%
% of Operating Profit
Other Income/Expense, Net -$824.0K -$18.58M
YoY Change -95.57%
Pretax Income -$17.13M -$23.13M
YoY Change -25.97%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$17.10M -$23.10M
YoY Change -25.97%
Net Earnings / Revenue -95000.0% -24574.47%
Basic Earnings Per Share -$0.68 -$1.80
Diluted Earnings Per Share -$0.68 -$1.80
COMMON SHARES
Basic Shares Outstanding 25.23M 12.82M
Diluted Shares Outstanding 25.23M 12.82M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.23M $764.0K
YoY Change 1500.26%
Cash & Equivalents $12.23M $764.0K $764.0K
Short-Term Investments
Other Short-Term Assets $752.0K $205.0K
YoY Change 266.83%
Inventory
Prepaid Expenses
Receivables $0.00 $18.00K $18.00K
Other Receivables $1.120M $1.036M
Total Short-Term Assets $14.10M $2.023M $2.023M
YoY Change 596.89%
LONG-TERM ASSETS
Property, Plant & Equipment $956.0K $682.0K $918.0K
YoY Change 4.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.000K $8.000K $8.000K
YoY Change -25.0%
Total Long-Term Assets $962.0K $926.0K $926.0K
YoY Change 3.89%
TOTAL ASSETS
Total Short-Term Assets $14.10M $2.023M $2.023M
Total Long-Term Assets $962.0K $926.0K $926.0K
Total Assets $15.06M $2.949M $2.949M
YoY Change 410.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $510.0K $227.0K $227.0K
YoY Change 124.67%
Accrued Expenses $990.0K $845.0K
YoY Change 17.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.510M $1.078M $1.078M
YoY Change 40.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $28.00K $20.00K
YoY Change 40.0%
Total Long-Term Liabilities $28.00K $20.00K
YoY Change 40.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.510M $1.078M $1.078M
Total Long-Term Liabilities $28.00K $20.00K
Total Liabilities $1.538M $1.098M $1.098M
YoY Change 40.07%
SHAREHOLDERS EQUITY
Retained Earnings -$57.95M
YoY Change
Common Stock $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.52M $1.851M $1.851M
YoY Change
Total Liabilities & Shareholders Equity $15.06M $2.949M $2.949M
YoY Change 410.68%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$17.10M -$23.10M
YoY Change -25.97%
Depreciation, Depletion And Amortization $209.0K $197.0K
YoY Change 6.09%
Cash From Operating Activities -$10.54M -$4.082M
YoY Change 158.11%
INVESTING ACTIVITIES
Capital Expenditures $341.0K $118.0K
YoY Change 188.98%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$341.0K -$118.0K
YoY Change 188.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.592M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 22.20M 4.592M
YoY Change 383.54%
NET CHANGE
Cash From Operating Activities -10.54M -4.082M
Cash From Investing Activities -341.0K -118.0K
Cash From Financing Activities 22.20M 4.592M
Net Change In Cash 11.33M 392.0K
YoY Change 2789.54%
FREE CASH FLOW
Cash From Operating Activities -$10.54M -$4.082M
Capital Expenditures $341.0K $118.0K
Free Cash Flow -$10.88M -$4.200M
YoY Change 158.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25233384
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12821748
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
682000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
154000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
236000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8000
CY2020Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
982000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
802000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
259000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1102000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
908000
CY2021 us-gaap Interest Expense
InterestExpense
19000
CY2020 us-gaap Interest Expense
InterestExpense
6835000
CY2021 us-gaap Interest Income Other
InterestIncomeOther
3000
CY2020 us-gaap Interest Income Other
InterestIncomeOther
3000
CY2020 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-6282000
CY2020 smtk Loss On Conversion Of Convertible Notes Payable
LossOnConversionOfConvertibleNotesPayable
5470000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
802000
CY2021Q2 dei Entity Public Float
EntityPublicFloat
0
CY2021Q4 us-gaap Assets Current
AssetsCurrent
14098000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2023000
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001817760
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13627887
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25554309
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.80
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-56181
CY2021 dei Entity Registrant Name
EntityRegistrantName
SmartKem, Inc.
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1083654
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
Manchester Technology Centre, Hexagon Tower.
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Delaunays Road
CY2021 dei Entity Address Address Line3
EntityAddressAddressLine3
Blackley
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Manchester
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
M9 8GQ
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
CY2021 dei City Area Code
CityAreaCode
44 161
CY2021 dei Local Phone Number
LocalPhoneNumber
721 1514
CY2021 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26566809
CY2021 dei Auditor Firm
AuditorFirmId
1295
CY2021 dei Auditor Name
AuditorName
BDO LLP
CY2021 dei Auditor Location
AuditorLocation
Manchester, United Kingdom
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12226000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
764000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18000
CY2021Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
1070000
CY2021Q4 us-gaap Assets
Assets
15060000
CY2020Q4 us-gaap Assets
Assets
2949000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1423000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
861000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1510000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1078000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20000
CY2021Q4 us-gaap Liabilities
Liabilities
1538000
CY2020Q4 us-gaap Liabilities
Liabilities
1098000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25554309
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13627887
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89954000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
61276000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1363000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1480000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75072000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57946000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13522000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1851000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15060000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2949000
CY2021 us-gaap Revenues
Revenues
18000
CY2020 us-gaap Revenues
Revenues
94000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
8000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
55000
CY2021 us-gaap Gross Profit
GrossProfit
10000
CY2020 us-gaap Gross Profit
GrossProfit
39000
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1285000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1437000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8199000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4319000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8069000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1707000
CY2021 smtk Transaction Expenses
TransactionExpenses
1329000
CY2021 us-gaap Operating Expenses
OperatingExpenses
17597000
CY2020 us-gaap Operating Expenses
OperatingExpenses
6026000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-16302000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-4550000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-808000
CY2020 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-824000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18583000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17126000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23133000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17126000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-23133000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17126000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-23133000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
117000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-284000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17009000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-23417000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.80
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25233384
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12821748
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-5083000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4592000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
25759000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-284000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-23133000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1851000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1851000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6196000
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
280000
CY2021 smtk Stock Issued During Period Value New Shares And Warrants Issued
StockIssuedDuringPeriodValueNewSharesAndWarrantsIssued
24638000
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2454000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
117000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17126000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13522000
CY2021 us-gaap Profit Loss
ProfitLoss
-17126000
CY2020 us-gaap Profit Loss
ProfitLoss
-23133000
CY2021 us-gaap Depreciation
Depreciation
209000
CY2020 us-gaap Depreciation
Depreciation
197000
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
263000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
234000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
176000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
6196000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6835000
CY2020 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-6282000
CY2020 smtk Loss On Conversion Of Convertible Notes Payable
LossOnConversionOfConvertibleNotesPayable
5470000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17000
CY2021 smtk Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
104000
CY2020 smtk Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-551000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
532000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
70000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-118000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
579000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-214000
CY2021 smtk Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-276000
CY2020 smtk Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-157000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10536000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4082000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
341000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
118000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-341000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
738000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
738000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4592000
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
24638000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2454000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22204000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4592000
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
135000
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-40000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11327000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
392000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
764000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
412000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12226000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
764000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
19000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
136000
CY2020 smtk Debt Conversion And Accrued Interest Into Common Shares
DebtConversionAndAccruedInterestIntoCommonShares
25759000
CY2021Q4 smtk Number Of Issued Patents
NumberOfIssuedPatents
120
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17100000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-23100000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75100000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12200000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Management’s Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and liabilities, at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The most significant estimates in the Company’s consolidated financial statements relates to the valuation of common share, fair value of share options, fair value of embedded conversion features in the convertible notes, and the valuation allowance of deferred tax assets. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Due to the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results may materially vary from these estimates. </p>
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2021Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. Periodically, the Company maintains deposits in financial institutions in excess of government insured limits. Management believes that the Company is not exposed to significant credit risk as the Company’s deposits are held at financial institutions that management believes to be of high credit quality and the Company has not experienced any losses in these deposits.</p>
CY2021Q4 us-gaap Property Plant And Equipment Salvage Value Percentage
PropertyPlantAndEquipmentSalvageValuePercentage
0.25
CY2021 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P15Y
CY2021 us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Derivative Asset for Embedded Conversion Features</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">The Company evaluates convertible notes to determine if those contracts or embedded components of those contracts qualify as derivatives to be accounted for separately. In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. The result of this accounting treatment is that the fair value of the embedded derivative is recorded as a liability and marked-to-market each balance sheet date, with the change in fair value recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">The fair value of the embedded conversion features are estimated using a Monte Carlo simulation model, in which possible outcomes and their values are simulated repeatedly and randomly. Under the Monte Carlo method the Company estimated the fair value of the convertible notes conversion feature at the time of issuance and subsequent remeasurement dates, utilizing the with-and without method, where the value of the derivative feature is the difference in values between a note simulated with the embedded conversion feature and the value of the same note simulated without the embedded conversion feature. Estimating fair values of embedded conversion features requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors.</p>
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1285000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1437000
CY2021Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
1070000
CY2020Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
982000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6196000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1810749
CY2020 smtk Debt Instrument Conversion Of Stock Into Equity
DebtInstrumentConversionOfStockIntoEquity
-23630000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2939415
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reclassifications</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">Certain amounts in prior years' consolidated financial statements have been recast and reclassified to conform to the current year's presentation</span>.</p>
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2454000
CY2021 smtk Transaction Expenses
TransactionExpenses
1329000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q4 smtk Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
217000
CY2020Q4 smtk Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
0
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
58000
CY2020Q4 us-gaap Prepaid Rent
PrepaidRent
65000
CY2021Q4 smtk Prepaid Utilities
PrepaidUtilities
51000
CY2020Q4 smtk Prepaid Utilities
PrepaidUtilities
30000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
412000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
41000
CY2021Q4 smtk Prepaid Administrative Expenses
PrepaidAdministrativeExpenses
63000
CY2020Q4 smtk Prepaid Administrative Expenses
PrepaidAdministrativeExpenses
61000
CY2021Q4 smtk Prepaid Technical Fees
PrepaidTechnicalFees
141000
CY2020Q4 smtk Prepaid Technical Fees
PrepaidTechnicalFees
8000
CY2021Q4 smtk Prepaid Consulting Fees
PrepaidConsultingFees
27000
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
50000
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
54000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
802000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
259000
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
128000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1423000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
861000
CY2020 us-gaap Sublease Income
SubleaseIncome
0
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1904000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1590000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1102000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
908000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
802000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
682000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
510000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
227000
CY2021Q4 smtk Accrued Liabilities Current Lab Refurbishment
AccruedLiabilitiesCurrentLabRefurbishment
131000
CY2020Q4 smtk Accrued Liabilities Current Lab Refurbishment
AccruedLiabilitiesCurrentLabRefurbishment
132000
CY2021Q4 smtk Accrued Technical Costs Current
AccruedTechnicalCostsCurrent
66000
CY2020Q4 smtk Accrued Technical Costs Current
AccruedTechnicalCostsCurrent
45000
CY2021Q4 smtk Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
20000
CY2020Q4 smtk Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
67000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
191000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
250000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
112000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6000
CY2021Q4 smtk Accrued Credit Card Liabilities Current
AccruedCreditCardLiabilitiesCurrent
10000
CY2020Q4 smtk Accrued Credit Card Liabilities Current
AccruedCreditCardLiabilitiesCurrent
6000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
383000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
115000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
237000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2021 us-gaap Sublease Income
SubleaseIncome
0
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
225000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
175000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
32000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
48000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
140000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
401000
CY2021 us-gaap Lease Cost
LeaseCost
397000
CY2020 us-gaap Lease Cost
LeaseCost
624000
CY2021 us-gaap Lease Cost
LeaseCost
397000
CY2020 us-gaap Lease Cost
LeaseCost
624000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
154000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
236000
CY2021Q4 smtk Operating Lease Assets Including Lease Assets Held For Sale
OperatingLeaseAssetsIncludingLeaseAssetsHeldForSale
154000
CY2020Q4 smtk Operating Lease Assets Including Lease Assets Held For Sale
OperatingLeaseAssetsIncludingLeaseAssetsHeldForSale
236000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
214000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
276000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
157000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
136000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M24D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0607
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0630
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
93000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
22000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
122000
CY2021Q4 smtk Lessee Operating Lease Future Minimum Short Term Lease Payments
LesseeOperatingLeaseFutureMinimumShortTermLeasePayments
3000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
115000
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
7280000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
25000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
6767000
CY2020 smtk Gross Loss On Conversion Of Convertible Notes Payable
GrossLossOnConversionOfConvertibleNotesPayable
9344000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.003
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2021 smtk Debt Instrument Increase Accrued Interest Expense Based On Stated Interest Rate
DebtInstrumentIncreaseAccruedInterestExpenseBasedOnStatedInterestRate
0
CY2020 smtk Debt Instrument Increase Accrued Interest Expense Based On Stated Interest Rate
DebtInstrumentIncreaseAccruedInterestExpenseBasedOnStatedInterestRate
43000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
25000
CY2020 smtk Gross Loss On Conversion Of Convertible Notes Payable
GrossLossOnConversionOfConvertibleNotesPayable
9344000
CY2020 smtk Gain Loss On Conversion Of Accrued Interest On Convertible Notes Payable
GainLossOnConversionOfAccruedInterestOnConvertibleNotesPayable
1046000
CY2020 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
4920000
CY2020Q1 smtk Cumulative Investment Proceeds From Common Stock Threshold Limit
CumulativeInvestmentProceedsFromCommonStockThresholdLimit
4600000
CY2020Q1 us-gaap Share Price
SharePrice
1.807011
CY2020Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
11796000
CY2020Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
8159977
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.45
CY2020Q1 smtk Debt Conversion Converted Instrument Interest Accrued Amount
DebtConversionConvertedInstrumentInterestAccruedAmount
1063000
CY2020Q1 smtk Debt Conversion Converted Instrument Interest Accrued Shares Issued
DebtConversionConvertedInstrumentInterestAccruedSharesIssued
735148
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.45
CY2020 smtk Loss On Conversion Of Convertible Notes Payable
LossOnConversionOfConvertibleNotesPayable
5470000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
6767000
CY2020Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.135
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1407000
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-6282000
CY2020 smtk Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain On Extinguishment Of Derivative Asset Upon Conversion
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainOnExtinguishmentOfDerivativeAssetUponConversion
4920000
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-45000
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-6282000
CY2020 smtk Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain On Extinguishment Of Derivative Asset Upon Conversion
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainOnExtinguishmentOfDerivativeAssetUponConversion
4920000
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
0
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1422000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.012
CY2021 smtk Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
10000000
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
160317
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y5M15D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.002
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.58
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18311
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M21D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
8.57245
CY2020 smtk Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Cancelled Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsCancelledNumberOfShares
86967
CY2020 smtk Share Based Compensation Arrangements By Share Based Payment Award Options Cancellation In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancellationInPeriodWeightedAverageExercisePrice
0.65226
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
90729
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.25578
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1828128
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.05051
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1810749
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.06143
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M12D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.46867
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1424622
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.01447
CY2021 smtk Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Cancelled Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsCancelledNumberOfShares
405936
CY2021 smtk Share Based Compensation Arrangements By Share Based Payment Award Options Cancellation In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancellationInPeriodWeightedAverageExercisePrice
0.06452
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
136221
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.00100
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2109912
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.68113
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1953882
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.72323
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M21D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.12355
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
465000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
336556
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.39318
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y1M24D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
465000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1953882
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.72323
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y3M21D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
465000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2400000
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6600000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.14
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.04
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6196000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1300000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5039000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-12087000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-23133000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17126000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23133000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.190
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.008
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.073
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.019
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.224
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.094
CY2020 smtk Effective Income Tax Rate Reconciliation Gain Loss On Convertible Debt Percent
EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleDebtPercent
-8.4
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.096
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.007
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7506000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3931000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
190000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
129000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
229000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
14000
CY2021Q4 smtk Deferred Tax Assets And Liabilities Gross
DeferredTaxAssetsAndLiabilitiesGross
7545000
CY2020Q4 smtk Deferred Tax Assets And Liabilities Gross
DeferredTaxAssetsAndLiabilitiesGross
3816000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7545000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3816000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
30674000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
20691000
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
5366000
CY2020 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
908000
CY2021 smtk Rent And Property Tax Expense
RentAndPropertyTaxExpense
24000
CY2020 smtk Rent And Property Tax Expense
RentAndPropertyTaxExpense
62000
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
486000
CY2021 smtk Utilities Expense
UtilitiesExpense
4000
CY2020 smtk Utilities Expense
UtilitiesExpense
1000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
749000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
96000
CY2021 us-gaap Professional Fees
ProfessionalFees
1132000
CY2020 us-gaap Professional Fees
ProfessionalFees
625000
CY2021 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
308000
CY2020 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
15000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8069000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1707000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
140000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
114000
CY2020Q4 smtk Defined Contribution Plan Due To Pension Fund
DefinedContributionPlanDueToPensionFund
0
CY2021Q4 smtk Defined Contribution Plan Due To Pension Fund
DefinedContributionPlanDueToPensionFund
0
CY2020Q4 us-gaap Notes Payable
NotesPayable
20000
CY2021Q4 us-gaap Notes Payable
NotesPayable
47500

Files In Submission

Name View Source Status
0001558370-22-004423-index-headers.html Edgar Link pending
0001558370-22-004423-index.html Edgar Link pending
0001558370-22-004423.txt Edgar Link pending
0001558370-22-004423-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20211231.xsd Edgar Link pending
tmb-20211231x10k.htm Edgar Link pending
tmb-20211231x10k_htm.xml Edgar Link completed
tmb-20211231xex10d21.htm Edgar Link pending
tmb-20211231xex23d1.htm Edgar Link pending
tmb-20211231xex31d1.htm Edgar Link pending
tmb-20211231xex31d2.htm Edgar Link pending
tmb-20211231xex32d1.htm Edgar Link pending
tmb-20211231xex32d2.htm Edgar Link pending
tmb-20211231xex4d4.htm Edgar Link pending
tmb-20211231_cal.xml Edgar Link unprocessable
tmb-20211231_def.xml Edgar Link unprocessable
tmb-20211231_lab.xml Edgar Link unprocessable
tmb-20211231_pre.xml Edgar Link unprocessable